STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
Recruiting
- Multiple Myeloma
- Relapse Multiple Myeloma
- Istanbul, TurkeyMedipol University
2021-10-04
Oct 4, 2021U
Recruiting
- Smoldering Multiple Myeloma
- Rochester, New YorkUniversity of Rochester
2021-07-07
Jul 7, 2021D
Suspended
- Smoldering Multiple Myeloma
- Nivolumab
- +2 more
- Boston, MassachusettsDana Farber Cancer Institute
2022-01-04
Jan 4, 2022D
Active, not recruiting
- Smoldering Multiple Myeloma
- Ixazomib
- +2 more
- Boston, MassachusettsDana Farber Cancer Institute
2022-03-15
Mar 15, 2022W
A
Not yet recruiting
- Multiple Myeloma Survival Outcome
- Bone marrow biopsy and compete blood count
- (no location specified)
2021-11-14
Nov 14, 2021C
Recruiting
- Multiple Myeloma
- Relapse Multiple Myeloma
- Bethesda, Maryland
- +1 more
2021-12-02
Dec 2, 2021B
No longer available
- Multiple Myeloma
- Elotuzumab
- (no location specified)
2021-11-17
Nov 17, 2021H
Recruiting
- Multiple Myeloma
- Relapsed and Refractory Multiple Myeloma
- Chengdu, Sichuan, ChinaHitGen Inc
2022-03-16
Mar 16, 2022R
Available
- Multiple Myeloma
- (no location specified)
2021-12-09
Dec 9, 2021B
Withdrawn
- Multiple Myeloma
- (no location specified)
2022-01-26
Jan 26, 2022N
Active, not recruiting
- Multiple Myeloma
- Carfilzomib
- +2 more
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022Z
Completed
- Multiple Myeloma
- Plasma-free procedure
- Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
2022-02-10
Feb 10, 2022C
Completed
- Multiple Myeloma
- Descartes-11
- +2 more
- Bethesda, Maryland
- +1 more
2022-03-10
Mar 10, 2022W
Recruiting
- Multiple Myeloma
- +2 more
- Daratumumab
- +3 more
- New York, New YorkWeill Cornell Medicine - Multiple Myeloma Center
2021-11-18
Nov 18, 2021M
Recruiting
- Multiple Myeloma
- +2 more
- TriPRIL CAR T Cells
- +2 more
- Boston, MassachusettsMassachusetts General Hospital Cancer Center
2021-10-28
Oct 28, 2021M
Active, not recruiting
- Multiple Myeloma
- Charlotte, North CarolinaLevine Cancer Institute
2022-01-21
Jan 21, 2022U
Not yet recruiting
- Multiple Myeloma
- (no location specified)
2021-12-15
Dec 15, 2021S
Recruiting
- Multiple Myeloma
- Melphalan
- +2 more
- Saint Petersburg, Russian FederationBoris V Afanasyev, MD, Prof.
2022-04-04
Apr 4, 2022I
Terminated
- Multiple Myeloma
- Cagliari, ItalyPresidio Ospedaliero R. Binaghi
2022-01-18
Jan 18, 2022S
Recruiting
- Multiple Myeloma
- +2 more
- BCMA CAR-T cells
- Shenzhen, Guangdong, ChinaLi Yu
2021-12-07
Dec 7, 2021Y
Completed
- Multiple Myeloma
- C11 Methionine positron emission tomography
- Boston, MassachusettsMassachusetts General Hospital
2021-09-15
Sep 15, 2021A
Not yet recruiting
- Multiple Myeloma
- +4 more
- Pembrolizumab
- San Francisco, CaliforniaUniversity of California, San Francisco
2022-03-23
Mar 23, 2022W
Recruiting
- Multiple Myeloma
- Isatuximab
- +2 more
- Saint Louis, MissouriWashington University School of Medicine
2022-04-01
Apr 1, 2022U
Active, not recruiting
- Multiple Myeloma
- ARM A EARLY INTERVENTION GROUP
- ARM B DELAYED INTERVENTION GROUP
- Birmingham, AlabamaUniversity of Alabama at Birmingham
2022-01-25
Jan 25, 2022